Welcome to our dedicated page for Doximity news (Ticker: DOCS), a resource for investors and traders seeking the latest updates and insights on Doximity stock.
Doximity reports news about its digital platform for U.S. medical professionals, including tools for clinical collaboration, medical news and research, career and on-call management, documentation workflows, and virtual patient visits. Company updates commonly cover quarterly financial results, platform engagement, workflow products, and AI-powered clinical reference and search capabilities.
Recurring developments also include Doximity Dialer telehealth recognition, physician research on AI adoption, and the integration of Pathway Medical into Doximity's clinical reference offerings. The company's news flow links product expansion with its verified medical-professional network and its role in digital workflow tools built for physicians.
Doximity (NYSE: DOCS) announced its participation in two virtual fireside chats at investor events. The first event is the SVB Leerink Virtual 11th Annual Global Healthcare Conference on February 16, 2022, where CFO Anna Bryson will present at 1:40 pm ET. The second event is the Morgan Stanley Technology, Media & Telecom Conference 2022 on March 10, 2022, featuring co-founder and CEO Jeff Tangney at 4:50 pm ET. Webcast links for both presentations will be available on Doximity's investor relations website.
Doximity (NYSE: DOCS) announced the acquisition of Amion, a top on-call physician scheduling platform, managing nearly 200,000 physician schedules across thousands of hospitals. This strategic move aims to enhance Doximity's physician cloud platform by integrating scheduling capabilities, which will drive engagement across its services. The acquisition is expected to be finalized on April 1, 2022, bridging a decade-long partnership between the two companies. Amion, recognized for its efficiency in scheduling, will leverage Doximity's growth potential to provide improved tools for physicians.
Doximity, Inc. (DOCS) reported a strong fiscal Q3 with revenue of $97.9 million, up 67% year-over-year. The company achieved a net income of $55.6 million with a net income margin of 57%. Key performance metrics included a 171% net revenue retention rate and an adjusted EBITDA of $47.0 million, growing 119% year-over-year. Doximity announced plans to acquire Amion, enhancing its offerings. Future guidance includes Q4 revenue between $89 million and $90 million, and for FY 2023, anticipated revenue growth of 33% to around $450 million.
Doximity, Inc. (NYSE: DOCS) announced that its Doximity Dialer has been recognized as the 2022 'Best in KLAS' in the Telehealth - Video Conferencing Platforms segment. This acknowledgment highlights Dialer's high ratings in culture, loyalty, operations, product, relationship, and value, where it received 'A' grades across the board. Doximity’s HIPAA-compliant platform facilitates one-click virtual visits and is widely adopted by over 150 hospitals, enhancing patient care and connection rates.
Doximity, Inc. (NYSE:DOCS) will report its financial results for Q3 2022, ending December 31, 2021, after market close on February 8, 2022. A conference call will follow at 2:00 p.m. PT (5:00 p.m. ET) to discuss these results. Renowned for being the leading digital platform for U.S. medical professionals, Doximity boasts over 80% of U.S. physicians in its network, providing tools for collaboration, updates on medical news, and virtual patient visits. The call will be accessible via the Company’s Investor Relations page.
Doximity, Inc. (NYSE: DOCS) released its fifth annual Physician Compensation Report, surveying over 46,000 full-time U.S. physicians. The report reveals a persistent gender pay gap, with female physicians earning 28% less than male counterparts, a difference exceeding $122,700. Additionally, 73% of physicians reported feeling overworked, and nearly 50% considered changing employment due to COVID-related stress. Physician compensation grew by 3.8% from 2020 to 2021, reflecting a tight labor market. The study highlights rising burnout rates and potential early retirement trends among physicians.
Doximity, Inc. (NYSE: DOCS) announced its participation in two upcoming virtual investor events. The first event is the Piper Sandler 33rd Annual Healthcare Conference, scheduled for November 22, 2021, featuring a pre-recorded presentation by Dr. Nate Gross at 10:00 am ET. The second event is the Raymond James Technology Conference on December 6, 2021, with a presentation by CFO Anna Bryson at 4:50 pm ET. Both presentations will be webcasted, with access available on Doximity's investor relations website.
Doximity, Inc. (DOCS) reported strong Q2 FY2022 results, with revenue of $79.4 million, a 76% increase year-over-year. Net income surged to $36.1 million, reflecting a 45% margin. The company achieved a record 173% net revenue retention rate and over 330,000 active telehealth providers. Doximity projects Q3 revenue between $85.8 million and $86.8 million and FY2022 revenue between $326.1 million and $328.1 million. The lock-up period for insiders will expire on November 12, 2021, allowing for potential share sales.
Doximity, Inc. (NYSE:DOCS) will announce its financial results for the second quarter ending September 30, 2021, on November 9, 2021, after market close. A conference call and webcast will take place at 2:00 p.m. PT (5:00 p.m. ET) on the same day to discuss these results. Founded in 2010, Doximity is a leading digital platform that serves over 80% of U.S. physicians, providing essential tools for collaboration, medical news, and virtual patient visits.
Doximity, Inc. (NYSE: DOCS) has launched its 2021-2022 Residency Navigator tool, which is extensively utilized by U.S. medical students. The tool offers insights on over 4,900 residency programs and includes a new Couples Match Tool, designed to help partners find geographically close residency options. The platform contains valuable features like Neighborhood Insights, personalized searches, real reviews from residents, and detailed program statistics, facilitating informed decisions for medical students.